{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:48:38Z","timestamp":1792705718835,"version":"4.5.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T00:00:00Z","timestamp":1625616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T00:00:00Z","timestamp":1625616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Autoimmune hepatitis is a chronic inflammatory hepatic disorder which may cause liver fibrosis. Appropriate treatment of autoimmune hepatitis is therefore important. Adult stem cells have been investigated as therapies for a variety of disorders in latest years. Hematopoietic stem cells (HSCs) were the first known adult stem cells (ASCs) and can give rise to all of the cell types in the blood and immune system. Originally, HSC transplantation was served as a therapy for hematological malignancies, but more recently researchers have found the treatment to have positive effects in autoimmune diseases such as multiple sclerosis. Mesenchymal stem cells (MSCs) are ASCs which can be extracted from different tissues, such as bone marrow, adipose tissue, umbilical cord, and dental pulp. MSCs interact with several immune response pathways either by direct cell-to-cell interactions or by the secretion of soluble factors. These characteristics make MSCs potentially valuable as a therapy for autoimmune diseases. Both ASC and ASC-derived exosomes have been investigated as a therapy for autoimmune hepatitis. This review aims to summarize studies focused on the effects of ASCs and their products on autoimmune hepatitis.<\/jats:p>","DOI":"10.1186\/s13287-021-02464-w","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T11:02:53Z","timestamp":1625655773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Stem cell therapies for autoimmune hepatitis"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9928-0724","authenticated-orcid":false,"given":"Ahmed","family":"Lotfy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Elgamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Burdzinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman A.","family":"Swelum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman A.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal","family":"Shiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,7]]},"reference":[{"issue":"1","key":"2464_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4254\/wjh.v3.i1.1","volume":"3","author":"J Mattner","year":"2011","unstructured":"Mattner J. Genetic susceptibility to autoimmune liver disease. World J Hepatol. 2011;3(1):1\u20137. Epub 2011\/02\/11. https:\/\/doi.org\/10.4254\/wjh.v3.i1.1.","journal-title":"World J Hepatol"},{"key":"2464_CR2","doi-asserted-by":"crossref","unstructured":"Zhou GP, Jiang YZ, Sun LY, Zhu ZJ. Therapeutic effect and safety of stem cell therapy for chronic liver disease: a systematic review and meta-analysis of randomized controlled trials. Stem cell Res Ther. 2020;11(1):1-19.","DOI":"10.1186\/s13287-020-01935-w"},{"issue":"9","key":"2464_CR3","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/1756-185X.13015","volume":"20","author":"J Liang","year":"2017","unstructured":"Liang J, Zhang H, Zhao C, Wang D, Ma X, Zhao S, et al. Effects of allogeneic mesenchymal stem cell transplantation in the treatment of liver cirrhosis caused by autoimmune diseases. Int J Rheum Dis. 2017;20(9):1219\u201326. Epub 2017\/02\/22. https:\/\/doi.org\/10.1111\/1756-185X.13015.","journal-title":"Int J Rheum Dis"},{"key":"2464_CR4","doi-asserted-by":"publisher","first-page":"204062232199344","DOI":"10.1177\/2040622321993442","volume":"12","author":"C He","year":"2021","unstructured":"He C, Yang Y, Zheng K, Chen Y, Liu S, Li Y, et al. Mesenchymal stem cell-based treatment in autoimmune liver diseases: underlying roles, advantages and challenges. Ther Adv Chronic Dis. 2021;12:204062232199344. https:\/\/doi.org\/10.1177\/2040622321993442.","journal-title":"Ther Adv Chronic Dis"},{"key":"2464_CR5","first-page":"19","volume":"48","author":"PM Brooks","year":"1997","unstructured":"Brooks PM. Hematopoietic stem cell transplantation for autoimmune diseases. J Rheumatol Suppl. 1997;48:19\u201322 Epub 1997\/05\/01.","journal-title":"J Rheumatol Suppl"},{"key":"2464_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/2782548","volume":"2019","author":"J AdiwinataPawitan","year":"2019","unstructured":"AdiwinataPawitan J. Exploring the most promising stem cell therapy in liver failure: a systematic review. Stem Cells Int. 2019;2019:1\u201315. https:\/\/doi.org\/10.1155\/2019\/2782548.","journal-title":"Stem Cells Int"},{"issue":"6","key":"2464_CR7","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/hep.23584","volume":"51","author":"MP Manns","year":"2010","unstructured":"Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51(6):2193\u2013213. Epub 2010\/06\/01. https:\/\/doi.org\/10.1002\/hep.23584.","journal-title":"Hepatology."},{"key":"2464_CR8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jaut.2012.11.002","volume":"41","author":"R Liberal","year":"2013","unstructured":"Liberal R, Grant CR, Mieli-Vergani G, Vergani D. Autoimmune hepatitis: a comprehensive review. J Autoimmun. 2013;41:126\u201339. Epub 2012\/12\/12. https:\/\/doi.org\/10.1016\/j.jaut.2012.11.002.","journal-title":"J Autoimmun"},{"issue":"1","key":"2464_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48(1):169\u201376. Epub 2008\/06\/10. https:\/\/doi.org\/10.1002\/hep.22322.","journal-title":"Hepatology."},{"issue":"1","key":"2464_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3748\/wjg.v21.i1.60","volume":"21","author":"NK Gatselis","year":"2015","unstructured":"Gatselis NK, Zachou K, Koukoulis GK, Dalekos GN. Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics. World J Gastroenterol. 2015;21(1):60\u201383. Epub 2015\/01\/13. https:\/\/doi.org\/10.3748\/wjg.v21.i1.60.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"2464_CR11","doi-asserted-by":"publisher","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","volume":"4","author":"G Mieli-Vergani","year":"2018","unstructured":"Mieli-Vergani G, Vergani D, Czaja AJ, Manns MP, Krawitt EL, Vierling JM, et al. Autoimmune hepatitis. Nat Rev Dis Primers. 2018;4(1):18017. Epub 2018\/04\/13. https:\/\/doi.org\/10.1038\/nrdp.2018.17.","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"2464_CR12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/apt.12042","volume":"36","author":"V Selvarajah","year":"2012","unstructured":"Selvarajah V, Montano-Loza AJ, Czaja AJ. Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs. Aliment Pharmacol Ther. 2012;36(8):691\u2013707. Epub 2012\/09\/15. https:\/\/doi.org\/10.1111\/apt.12042.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"2464_CR13","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.bbadis.2018.05.017","volume":"1865","author":"U Christen","year":"2019","unstructured":"Christen U. Animal models of autoimmune hepatitis. Biochim Biophys Acta Mol basis Dis. 2019;1865(5):970\u201381. Epub 2018\/06\/02. https:\/\/doi.org\/10.1016\/j.bbadis.2018.05.017.","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"issue":"1","key":"2464_CR14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1172\/JCI115836","volume":"90","author":"G Tiegs","year":"1992","unstructured":"Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest. 1992;90(1):196\u2013203. Epub 1992\/07\/01. https:\/\/doi.org\/10.1172\/JCI115836.","journal-title":"J Clin Invest"},{"key":"2464_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1146\/annurev.pa.30.040190.001125","volume":"30","author":"SD Nelson","year":"1990","unstructured":"Nelson SD, Pearson PG. Covalent and noncovalent interactions in acute lethal cell injury caused by chemicals. Annu Rev Pharmacol Toxicol. 1990;30:169\u201395. Epub 1990\/01\/01. https:\/\/doi.org\/10.1146\/annurev.pa.30.040190.001125.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1 Suppl","key":"2464_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/0023677215572841","volume":"49","author":"F Heymann","year":"2015","unstructured":"Heymann F, Hamesch K, Weiskirchen R, Tacke F. The concanavalin A model of acute hepatitis in mice. Lab Anim. 2015;49(1 Suppl):12\u201320. Epub 2015\/04\/04. https:\/\/doi.org\/10.1177\/0023677215572841.","journal-title":"Lab Anim"},{"issue":"3","key":"2464_CR17","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/0016-5085(83)90085-9","volume":"84","author":"J Kuriki","year":"1983","unstructured":"Kuriki J, Murakami H, Kakumu S, Sakamoto N, Yokochi T, Nakashima I, et al. Experimental autoimmune hepatitis in mice after immunization with syngeneic liver proteins together with the polysaccharide of Klebsiella pneumoniae. Gastroenterology. 1983;84(3):596\u2013603. Epub 1983\/03\/01. https:\/\/doi.org\/10.1016\/0016-5085(83)90085-9.","journal-title":"Gastroenterology."},{"issue":"6","key":"2464_CR18","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1002\/hep.510270611","volume":"27","author":"AW Lohse","year":"1998","unstructured":"Lohse AW, Dienes HP. Meyer zum Buschenfelde KH. Suppression of murine experimental autoimmune hepatitis by T-cell vaccination or immunosuppression. Hepatology. 1998;27(6):1536\u201343. Epub 1998\/06\/10. https:\/\/doi.org\/10.1002\/hep.510270611.","journal-title":"Hepatology."},{"issue":"8","key":"2464_CR19","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","volume":"14","author":"Y Shi","year":"2018","unstructured":"Shi Y, Wang Y, Li Q, Liu K, Hou J, Shao C. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol. 2018;14(8):493\u2013507. Epub 2018\/06\/14. https:\/\/doi.org\/10.1038\/s41581-018-0023-5.","journal-title":"Nat Rev Nephrol"},{"key":"2464_CR20","doi-asserted-by":"publisher","first-page":"6484038","DOI":"10.1155\/2016\/6484038","volume":"2016","author":"GA Ferraro","year":"2016","unstructured":"Ferraro GA, Mizuno H, Pallua N. Adipose stem cells: from bench to bedside. Stem Cells Int. 2016;2016:6484038 Epub 2016\/04\/19.","journal-title":"Stem Cells Int"},{"issue":"2","key":"2464_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.15283\/ijsc.2014.7.2.135","volume":"7","author":"A Lotfy","year":"2014","unstructured":"Lotfy A, Salama M, Zahran F, Jones E, Badawy A, Sobh M. Characterization of mesenchymal stem cells derived from rat bone marrow and adipose tissue: a comparative study. Int J Stem Cells. 2014;7(2):135\u201342. Epub 2014\/12\/05. https:\/\/doi.org\/10.15283\/ijsc.2014.7.2.135.","journal-title":"Int J Stem Cells"},{"issue":"4","key":"2464_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3892\/br.2019.1236","volume":"11","author":"A Lotfy","year":"2019","unstructured":"Lotfy A, El-Sherbiny YM, Cuthbert R, Jones E, Badawy A. Comparative study of biological characteristics of mesenchymal stem cells isolated from mouse bone marrow and peripheral blood. Biomed Rep. 2019;11(4):165\u201370. Epub 2019\/10\/01. https:\/\/doi.org\/10.3892\/br.2019.1236.","journal-title":"Biomed Rep"},{"key":"2464_CR23","doi-asserted-by":"crossref","unstructured":"Gaber T, Schonbeck K, Hoff H, Tran CL, Strehl C, Lang A, et al. CTLA-4 mediates inhibitory function of mesenchymal stem\/stromal cells. Int J Mol Sci. 2018;19(8) Epub 2018\/08\/09.","DOI":"10.3390\/ijms19082312"},{"issue":"1","key":"2464_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev-pathol-020117-043534","volume":"13","author":"GJ Webb","year":"2018","unstructured":"Webb GJ, Hirschfield GM, Krawitt EL, Gershwin ME. Cellular and molecular mechanisms of autoimmune hepatitis. Annu Rev Pathol. 2018;13(1):247\u201392. Epub 2017\/11\/16. https:\/\/doi.org\/10.1146\/annurev-pathol-020117-043534.","journal-title":"Annu Rev Pathol"},{"issue":"3","key":"2464_CR25","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/stem.2509","volume":"35","author":"LC Davies","year":"2017","unstructured":"Davies LC, Heldring N, Kadri N, Le Blanc K. Mesenchymal stromal cell secretion of programmed death-1 ligands regulates T cell mediated immunosuppression. Stem Cells. 2017;35(3):766\u201376. Epub 2016\/10\/27. https:\/\/doi.org\/10.1002\/stem.2509.","journal-title":"Stem Cells"},{"key":"2464_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bbrep.2016.07.019","volume":"8","author":"L Meesuk","year":"2016","unstructured":"Meesuk L, Tantrawatpan C, Kheolamai P, Manochantr S. The immunosuppressive capacity of human mesenchymal stromal cells derived from amnion and bone marrow. Biochem Biophysics Rep. 2016;8:34\u201340. Epub 2017\/09\/29. https:\/\/doi.org\/10.1016\/j.bbrep.2016.07.019.","journal-title":"Biochem Biophysics Rep"},{"issue":"1","key":"2464_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13287-020-02087-7","volume":"12","author":"JY Lim","year":"2021","unstructured":"Lim JY, Kim BS, Ryu DB, Kim TW, Park G, Min CK. The therapeutic efficacy of mesenchymal stromal cells on experimental colitis was improved by the IFN-gamma and poly(I:C) priming through promoting the expression of indoleamine 2,3-dioxygenase. Stem Cell Res Ther. 2021;12(1):37. Epub 2021\/01\/09. https:\/\/doi.org\/10.1186\/s13287-020-02087-7.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"2464_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12712","volume":"53","author":"W Jiang","year":"2020","unstructured":"Jiang W, Xu J. Immune modulation by mesenchymal stem cells. Cell Prolif. 2020;53(1):e12712. Epub 2019\/11\/16. https:\/\/doi.org\/10.1111\/cpr.12712.","journal-title":"Cell Prolif"},{"issue":"5","key":"2464_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/scrt322","volume":"4","author":"I Atsuta","year":"2013","unstructured":"Atsuta I, Liu S, Miura Y, Akiyama K, Chen C, An Y, et al. Mesenchymal stem cells inhibit multiple myeloma cells via the Fas\/Fas ligand pathway. Stem Cell Res Ther. 2013;4(5):111. Epub 2013\/09\/13. https:\/\/doi.org\/10.1186\/scrt322.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"2464_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/scrt216","volume":"4","author":"P Luz-Crawford","year":"2013","unstructured":"Luz-Crawford P, Kurte M, Bravo-Alegria J, Contreras R, Nova-Lamperti E, Tejedor G, et al. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells. Stem Cell Res Ther. 2013;4(3):65. Epub 2013\/06\/06. https:\/\/doi.org\/10.1186\/scrt216.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"2464_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1365-2249.2009.03874.x","volume":"156","author":"K English","year":"2009","unstructured":"English K, Ryan JM, Tobin L, Murphy MJ, Barry FP, Mahon BP. Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. Clin Exp Immunol. 2009;156(1):149\u201360. Epub 2009\/02\/13. https:\/\/doi.org\/10.1111\/j.1365-2249.2009.03874.x.","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"2464_CR32","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1002\/stem.1432","volume":"31","author":"SM Melief","year":"2013","unstructured":"Melief SM, Schrama E, Brugman MH, Tiemessen MM, Hoogduijn MJ, Fibbe WE, et al. Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages. Stem Cells. 2013;31(9):1980\u201391. Epub 2013\/05\/29. https:\/\/doi.org\/10.1002\/stem.1432.","journal-title":"Stem Cells"},{"issue":"10","key":"2464_CR33","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1002\/eji.201141499","volume":"41","author":"MM Duffy","year":"2011","unstructured":"Duffy MM, Pindjakova J, Hanley SA, McCarthy C, Weidhofer GA, Sweeney EM, et al. Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor. Eur J Immunol. 2011;41(10):2840\u201351. Epub 2011\/06\/29. https:\/\/doi.org\/10.1002\/eji.201141499.","journal-title":"Eur J Immunol"},{"issue":"11","key":"2464_CR34","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/ni.3002","volume":"15","author":"Y Wang","year":"2014","unstructured":"Wang Y, Chen X, Cao W, Shi Y. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat Immunol. 2014;15(11):1009\u201316. Epub 2014\/10\/21. https:\/\/doi.org\/10.1038\/ni.3002.","journal-title":"Nat Immunol"},{"issue":"18","key":"2464_CR35","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1089\/scd.2015.0008","volume":"24","author":"H Munir","year":"2015","unstructured":"Munir H, McGettrick HM. Mesenchymal stem cell therapy for autoimmune disease: risks and rewards. Stem Cells Dev. 2015;24(18):2091\u2013100. Epub 2015\/06\/13. https:\/\/doi.org\/10.1089\/scd.2015.0008.","journal-title":"Stem Cells Dev"},{"issue":"1","key":"2464_CR36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1146\/annurev-immunol-032712-095919","volume":"31","author":"PS Frenette","year":"2013","unstructured":"Frenette PS, Pinho S, Lucas D, Scheiermann C. Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine. Annu Rev Immunol. 2013;31(1):285\u2013316. Epub 2013\/01\/10. https:\/\/doi.org\/10.1146\/annurev-immunol-032712-095919.","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"2464_CR37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12026-020-09132-w","volume":"68","author":"H El-Gendy","year":"2020","unstructured":"El-Gendy H, Hawass SE, Awad M, Mohsen MA, Amin M, Abdalla HA, et al. Comparative study between human mesenchymal stem cells and etanercept as immunomodulatory agents in rat model of rheumatoid arthritis. Immunol Res. 2020;68(5):255\u201368. Epub 2020\/08\/01. https:\/\/doi.org\/10.1007\/s12026-020-09132-w.","journal-title":"Immunol Res"},{"issue":"2","key":"2464_CR38","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","volume":"2","author":"G Ren","year":"2008","unstructured":"Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008;2(2):141\u201350. Epub 2008\/03\/29. https:\/\/doi.org\/10.1016\/j.stem.2007.11.014.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"2464_CR39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1515\/revneuro-2019-0040","volume":"31","author":"A Lotfy","year":"2020","unstructured":"Lotfy A, Ali NS, Abdelgawad M, Salama M. Mesenchymal stem cells as a treatment for multiple sclerosis: a focus on experimental animal studies. Rev Neurosci. 2020;31(2):161\u201379. Epub 2019\/10\/13. https:\/\/doi.org\/10.1515\/revneuro-2019-0040.","journal-title":"Rev Neurosci"},{"issue":"10","key":"2464_CR40","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1111\/cas.13334","volume":"108","author":"HY Lee","year":"2017","unstructured":"Lee HY, Hong IS. Double-edged sword of mesenchymal stem cells: cancer-promoting versus therapeutic potential. Cancer Sci. 2017;108(10):1939\u201346. Epub 2017\/08\/02. https:\/\/doi.org\/10.1111\/cas.13334.","journal-title":"Cancer Sci"},{"issue":"1","key":"2464_CR41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.5966\/sctm.2011-0019","volume":"1","author":"G Ren","year":"2012","unstructured":"Ren G, Chen X, Dong F, Li W, Ren X, Zhang Y, et al. Concise review: mesenchymal stem cells and translational medicine: emerging issues. Stem Cells Transl Med. 2012;1(1):51\u20138. Epub 2012\/12\/01. https:\/\/doi.org\/10.5966\/sctm.2011-0019.","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"2464_CR42","first-page":"21","volume":"23","author":"L Bian","year":"2009","unstructured":"Bian L, Guo ZK, Wang HX, Wang JS, Wang H, Li QF, et al. In vitro and in vivo immunosuppressive characteristics of hepatocyte growth factor-modified murine mesenchymal stem cells. In Vivo. 2009;23(1):21\u20137 Epub 2009\/04\/17.","journal-title":"In Vivo"},{"issue":"15","key":"2464_CR43","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/sj.gt.3302741","volume":"13","author":"A Li","year":"2006","unstructured":"Li A, Zhang Q, Jiang J, Yuan G, Feng Y, Hao J, et al. Co-transplantation of bone marrow stromal cells transduced with IL-7 gene enhances immune reconstitution after allogeneic bone marrow transplantation in mice. Gene Ther. 2006;13(15):1178\u201387. Epub 2006\/04\/07. https:\/\/doi.org\/10.1038\/sj.gt.3302741.","journal-title":"Gene Ther"},{"issue":"10","key":"2464_CR44","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/sj.bmt.1705644","volume":"39","author":"CK Min","year":"2007","unstructured":"Min CK, Kim BG, Park G, Cho B, Oh IH. IL-10-transduced bone marrow mesenchymal stem cells can attenuate the severity of acute graft-versus-host disease after experimental allogeneic stem cell transplantation. Bone Marrow Transplant. 2007;39(10):637\u201345. Epub 2007\/03\/21. https:\/\/doi.org\/10.1038\/sj.bmt.1705644.","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"2464_CR45","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12967-015-0638-2","volume":"13","author":"H Qi","year":"2015","unstructured":"Qi H, Chen G, Huang Y, Si Z, Li J. Foxp3-modified bone marrow mesenchymal stem cells promotes liver allograft tolerance through the generation of regulatory T cells in rats. J Transl Med. 2015;13(1):274. Epub 2015\/08\/22. https:\/\/doi.org\/10.1186\/s12967-015-0638-2.","journal-title":"J Transl Med"},{"issue":"2 Pt B","key":"2464_CR46","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.imlet.2014.10.021","volume":"162","author":"Y Chen","year":"2014","unstructured":"Chen Y, Chen S, Liu LY, Zou ZL, Cai YJ, Wang JG, et al. Mesenchymal stem cells ameliorate experimental autoimmune hepatitis by activation of the programmed death 1 pathway. Immunol Lett. 2014;162(2 Pt B):222\u20138 Epub 2014\/12\/03.","journal-title":"Immunol Lett"},{"issue":"2","key":"2464_CR47","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1089\/hum.2017.171","volume":"29","author":"W Wang","year":"2018","unstructured":"Wang W, Guo H, Li H, Yan Y, Wu C, Wang X, et al. Interleukin-35 gene-modified mesenchymal stem cells protect concanavalin A-induced fulminant hepatitis by decreasing the interferon gamma level. Hum Gene Ther. 2018;29(2):234\u201341. Epub 2017\/10\/22. https:\/\/doi.org\/10.1089\/hum.2017.171.","journal-title":"Hum Gene Ther"},{"key":"2464_CR48","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.molimm.2017.11.008","volume":"93","author":"L Chen","year":"2018","unstructured":"Chen L, Lu FB, Chen DZ, Wu JL, Hu ED, Xu LM, et al. BMSCs-derived miR-223-containing exosomes contribute to liver protection in experimental autoimmune hepatitis. Mol Immunol. 2018;93:38\u201346. Epub 2017\/11\/18. https:\/\/doi.org\/10.1016\/j.molimm.2017.11.008.","journal-title":"Mol Immunol"},{"issue":"12","key":"2464_CR49","doi-asserted-by":"publisher","first-page":"906","DOI":"10.14348\/molcells.2019.2283","volume":"42","author":"FB Lu","year":"2019","unstructured":"Lu FB, Chen DZ, Chen L, Hu ED, Wu JL, Li H, et al. Attenuation of experimental autoimmune hepatitis in mice with bone mesenchymal stem cell-derived exosomes carrying microRNA-223-3p. Mol Cell. 2019;42(12):906\u201318. Epub 2019\/12\/13. https:\/\/doi.org\/10.14348\/molcells.2019.2283.","journal-title":"Mol Cell"},{"key":"2464_CR50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cellimm.2016.12.001","volume":"312","author":"N Zhao","year":"2017","unstructured":"Zhao N, Li H, Yan Y, Jiang R, He X. Mesenchymal stem cells overexpressing IL-35 effectively inhibit CD4(+) T cell function. Cell Immunol. 2017;312:61\u20136. Epub 2016\/12\/21. https:\/\/doi.org\/10.1016\/j.cellimm.2016.12.001.","journal-title":"Cell Immunol"},{"issue":"6","key":"2464_CR51","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.cell.2016.01.043","volume":"164","author":"M Tkach","year":"2016","unstructured":"Tkach M, Thery C. Communication by extracellular vesicles: where we are and where we need to go. Cell. 2016;164(6):1226\u201332. Epub 2016\/03\/12. https:\/\/doi.org\/10.1016\/j.cell.2016.01.043.","journal-title":"Cell."},{"key":"2464_CR52","doi-asserted-by":"publisher","first-page":"6574010","DOI":"10.1155\/2020\/6574010","volume":"2020","author":"G Shiha","year":"2020","unstructured":"Shiha G, Nabil A, Lotfy A, Soliman R, Hassan AA, Ali IS, et al. Antifibrotic effect of combination of nilotinib and stem cell-conditioned media on CCl4-induced liver fibrosis. Stem Cells Int. 2020;2020:6574010 Epub 2020\/02\/25.","journal-title":"Stem Cells Int"},{"issue":"12","key":"2464_CR53","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/stem.1409","volume":"31","author":"H Xin","year":"2013","unstructured":"Xin H, Li Y, Liu Z, Wang X, Shang X, Cui Y, et al. MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells. 2013;31(12):2737\u201346. Epub 2013\/05\/01. https:\/\/doi.org\/10.1002\/stem.1409.","journal-title":"Stem Cells"},{"issue":"12","key":"2464_CR54","first-page":"23222","volume":"9","author":"DAE Mohamed Abouelkheir","year":"2016","unstructured":"Mohamed Abouelkheir DAE, Saad M-A, Abdelrahman KM, Sobh M-A, Lotfy A, Sobh MA. Mesenchymal stem cells versus their conditioned medium in the treatment of cisplatin-induced acute kidney injury: evaluation of efficacy and cellular side effects. Int J Clin Exp Med. 2016;9(12):23222\u201334.","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"2464_CR55","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1365-2249.2010.04271.x","volume":"163","author":"S Sadallah","year":"2011","unstructured":"Sadallah S, Eken C, Schifferli JA. Ectosomes as modulators of inflammation and immunity. Clin Exp Immunol. 2011;163(1):26\u201332. Epub 2010\/11\/03. https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04271.x.","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"2464_CR56","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/leu.2014.41","volume":"28","author":"L Kordelas","year":"2014","unstructured":"Kordelas L, Rebmann V, Ludwig AK, Radtke S, Ruesing J, Doeppner TR, et al. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia. 2014;28(4):970\u20133. Epub 2014\/01\/22. https:\/\/doi.org\/10.1038\/leu.2014.41.","journal-title":"Leukemia."},{"issue":"3","key":"2464_CR57","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/scrt465","volume":"5","author":"CY Tan","year":"2014","unstructured":"Tan CY, Lai RC, Wong W, Dan YY, Lim SK, Ho HK. Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models. Stem Cell Res Ther. 2014;5(3):76. Epub 2014\/06\/12. https:\/\/doi.org\/10.1186\/scrt465.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"2464_CR58","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.stemcr.2017.04.008","volume":"8","author":"T Shigemoto-Kuroda","year":"2017","unstructured":"Shigemoto-Kuroda T, Oh JY, Kim DK, Jeong HJ, Park SY, Lee HJ, et al. MSC-derived extracellular vesicles attenuate immune responses in two autoimmune murine models: type 1 diabetes and uveoretinitis. Stem Cell Rep. 2017;8(5):1214\u201325. Epub 2017\/05\/13. https:\/\/doi.org\/10.1016\/j.stemcr.2017.04.008.","journal-title":"Stem Cell Rep"},{"issue":"12","key":"2464_CR59","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1111\/j.1600-0854.2011.01225.x","volume":"12","author":"A Bobrie","year":"2011","unstructured":"Bobrie A, Colombo M, Raposo G, Thery C. Exosome secretion: molecular mechanisms and roles in immune responses. Traffic. 2011;12(12):1659\u201368. Epub 2011\/06\/08. https:\/\/doi.org\/10.1111\/j.1600-0854.2011.01225.x.","journal-title":"Traffic."},{"issue":"2","key":"2464_CR60","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2307\/3570892","volume":"14","author":"JE Till","year":"1961","unstructured":"Till JE, Mc CE. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res. 1961;14(2):213\u201322. Epub 1961\/02\/01. https:\/\/doi.org\/10.2307\/3570892.","journal-title":"Radiat Res"},{"issue":"1","key":"2464_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15283\/ijsc19127","volume":"13","author":"JY Lee","year":"2020","unstructured":"Lee JY, Hong SH. Hematopoietic stem cells and their roles in tissue regeneration. Int J Stem Cells. 2020;13(1):1\u201312. Epub 2020\/01\/01. https:\/\/doi.org\/10.15283\/ijsc19127.","journal-title":"Int J Stem Cells"},{"issue":"2","key":"2464_CR62","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/35100573","volume":"1","author":"MJ Shlomchik","year":"2001","unstructured":"Shlomchik MJ, Craft JE, Mamula MJ. From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol. 2001;1(2):147\u201353. Epub 2002\/03\/22. https:\/\/doi.org\/10.1038\/35100573.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2464_CR63","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/bmt.2014.251","volume":"50","author":"T Alexander","year":"2015","unstructured":"Alexander T, Bondanza A, Muraro PA, Greco R, Saccardi R, Daikeler T, et al. SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking. Bone Marrow Transplant. 2015;50(2):173\u201380. Epub 2014\/11\/12. https:\/\/doi.org\/10.1038\/bmt.2014.251.","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2464_CR64","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/bmt.2011.185","volume":"47","author":"JA Snowden","year":"2012","unstructured":"Snowden JA, Saccardi R, Allez M, Ardizzone S, Arnold R, Cervera R, et al. Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2012;47(6):770\u201390. Epub 2011\/10\/18. https:\/\/doi.org\/10.1038\/bmt.2011.185.","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"2464_CR65","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.bbmt.2019.02.014","volume":"25","author":"JA Cohen","year":"2019","unstructured":"Cohen JA, Baldassari LE, Atkins HL, Bowen JD, Bredeson C, Carpenter PA, et al. Autologous hematopoietic cell transplantation for treatment-refractory relapsing multiple sclerosis: position statement from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2019;25(5):845\u201354. Epub 2019\/02\/23. https:\/\/doi.org\/10.1016\/j.bbmt.2019.02.014.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"2464_CR66","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.bbmt.2018.06.025","volume":"24","author":"KM Sullivan","year":"2018","unstructured":"Sullivan KM, Majhail NS, Bredeson C, Carpenter PA, Chatterjee S, Crofford LJ, et al. Systemic sclerosis as an indication for autologous hematopoietic cell transplantation: position statement from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2018;24(10):1961\u20134. Epub 2018\/06\/29. https:\/\/doi.org\/10.1016\/j.bbmt.2018.06.025.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"2464_CR67","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/MOH.0000000000000531","volume":"26","author":"SA Ng","year":"2019","unstructured":"Ng SA, Sullivan KM. Application of stem cell transplantation in autoimmune diseases. Curr Opin Hematol. 2019;26(6):392\u20138. Epub 2019\/09\/07. https:\/\/doi.org\/10.1097\/MOH.0000000000000531.","journal-title":"Curr Opin Hematol"},{"issue":"6","key":"2464_CR68","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1182\/blood-2011-02-336156","volume":"118","author":"T Daikeler","year":"2011","unstructured":"Daikeler T, Labopin M, Di Gioia M, Abinun M, Alexander T, Miniati I, et al. Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party. Blood. 2011;118(6):1693\u20138. Epub 2011\/05\/21. https:\/\/doi.org\/10.1182\/blood-2011-02-336156.","journal-title":"Blood."},{"issue":"27","key":"2464_CR69","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1182\/bloodadvances.2017010041","volume":"1","author":"JA Snowden","year":"2017","unstructured":"Snowden JA, Badoglio M, Labopin M, Giebel S, McGrath E, Marjanovic Z, et al. Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases. Blood Adv. 2017;1(27):2742\u201355. Epub 2018\/01\/04. https:\/\/doi.org\/10.1182\/bloodadvances.2017010041.","journal-title":"Blood Adv"},{"issue":"1","key":"2464_CR70","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","volume":"236","author":"LM Francisco","year":"2010","unstructured":"Francisco LM, Sage PT, Sharpe AH. The PD-1 pathway in tolerance and autoimmunity. Immunol Rev. 2010;236(1):219\u201342. Epub 2010\/07\/20. https:\/\/doi.org\/10.1111\/j.1600-065X.2010.00923.x.","journal-title":"Immunol Rev"},{"issue":"7169","key":"2464_CR71","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nature06306","volume":"450","author":"LW Collison","year":"2007","unstructured":"Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature. 2007;450(7169):566\u20139. Epub 2007\/11\/23. https:\/\/doi.org\/10.1038\/nature06306.","journal-title":"Nature."},{"key":"2464_CR72","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12950-017-0164-5","volume":"14","author":"A Huang","year":"2017","unstructured":"Huang A, Cheng L, He M, Nie J, Wang J, Jiang K. Interleukin-35 on B cell and T cell induction and regulation. J Inflamm (Lond). 2017;14:16 Epub 2017\/08\/11.","journal-title":"J Inflamm (Lond)"},{"key":"2464_CR73","first-page":"5931865","volume":"2017","author":"P Gao","year":"2017","unstructured":"Gao P, Su Z, Lv X, Zhang J. Interluekin-35 in asthma and its potential as an effective therapeutic agent. Mediat Inflamm. 2017;2017:5931865 Epub 2017\/05\/30.","journal-title":"Mediat Inflamm"},{"issue":"1","key":"2464_CR74","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10753-016-0453-9","volume":"40","author":"SY Guan","year":"2017","unstructured":"Guan SY, Leng RX, Khan MI, Qureshi H, Li XP, Ye DQ, et al. Interleukin-35: a potential therapeutic agent for autoimmune diseases. Inflammation. 2017;40(1):303\u201310. Epub 2016\/10\/04. https:\/\/doi.org\/10.1007\/s10753-016-0453-9.","journal-title":"Inflammation."},{"issue":"13","key":"2464_CR75","doi-asserted-by":"publisher","first-page":"R568","DOI":"10.1016\/j.cub.2016.02.019","volume":"26","author":"L Vande Walle","year":"2016","unstructured":"Vande Walle L, Lamkanfi M. Pyroptosis. Curr Biol. 2016;26(13):R568\u2013R72. Epub 2016\/07\/13. https:\/\/doi.org\/10.1016\/j.cub.2016.02.019.","journal-title":"Curr Biol"},{"issue":"5","key":"2464_CR76","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.cell.2014.04.007","volume":"157","author":"M Lamkanfi","year":"2014","unstructured":"Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell. 2014;157(5):1013\u201322. Epub 2014\/05\/27. https:\/\/doi.org\/10.1016\/j.cell.2014.04.007.","journal-title":"Cell."},{"issue":"5","key":"2464_CR77","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/ni.3389","volume":"17","author":"BN Martin","year":"2016","unstructured":"Martin BN, Wang C, Zhang CJ, Kang Z, Gulen MF, Zepp JA, et al. T cell-intrinsic ASC critically promotes T(H)17-mediated experimental autoimmune encephalomyelitis. Nat Immunol. 2016;17(5):583\u201392. Epub 2016\/03\/22. https:\/\/doi.org\/10.1038\/ni.3389.","journal-title":"Nat Immunol"},{"issue":"2","key":"2464_CR78","doi-asserted-by":"publisher","first-page":"974","DOI":"10.4049\/jimmunol.0904145","volume":"185","author":"D Gris","year":"2010","unstructured":"Gris D, Ye Z, Iocca HA, Wen H, Craven RR, Gris P, et al. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. J Immunol. 2010;185(2):974\u201381. Epub 2010\/06\/25. https:\/\/doi.org\/10.4049\/jimmunol.0904145.","journal-title":"J Immunol"},{"issue":"6","key":"2464_CR79","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.smim.2007.10.015","volume":"19","author":"Z Chen","year":"2007","unstructured":"Chen Z, Laurence A, O'Shea JJ. Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation. Semin Immunol. 2007;19(6):400\u20138. Epub 2008\/01\/02. https:\/\/doi.org\/10.1016\/j.smim.2007.10.015.","journal-title":"Semin Immunol"},{"issue":"7090","key":"2464_CR80","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441(7090):235\u20138. Epub 2006\/05\/02. https:\/\/doi.org\/10.1038\/nature04753.","journal-title":"Nature."},{"key":"2464_CR81","doi-asserted-by":"publisher","first-page":"345803","DOI":"10.1155\/2011\/345803","volume":"2011","author":"L Hammerich","year":"2011","unstructured":"Hammerich L, Heymann F, Tacke F. Role of IL-17 and Th17 cells in liver diseases. Clin Dev Immunol. 2011;2011:345803 Epub 2011\/01\/05.","journal-title":"Clin Dev Immunol"},{"issue":"2","key":"2464_CR82","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.clim.2008.12.008","volume":"131","author":"F Deknuydt","year":"2009","unstructured":"Deknuydt F, Bioley G, Valmori D, Ayyoub M. IL-1beta and IL-2 convert human Treg into T(H)17 cells. Clin Immunol. 2009;131(2):298\u2013307. Epub 2009\/02\/13. https:\/\/doi.org\/10.1016\/j.clim.2008.12.008.","journal-title":"Clin Immunol"},{"issue":"11","key":"2464_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143715","volume":"10","author":"I An Haack","year":"2015","unstructured":"An Haack I, Derkow K, Riehn M, Rentinck MN, Kuhl AA, Lehnardt S, et al. The role of regulatory CD4 T cells in maintaining tolerance in a mouse model of autoimmune hepatitis. PLoS One. 2015;10(11):e0143715. Epub 2015\/11\/26. https:\/\/doi.org\/10.1371\/journal.pone.0143715.","journal-title":"PLoS One"},{"issue":"5 Pt 2","key":"2464_CR84","doi-asserted-by":"publisher","first-page":"26R","DOI":"10.1203\/PDR.0b013e31819e76c7","volume":"65","author":"EM Eisenstein","year":"2009","unstructured":"Eisenstein EM, Williams CB. The T(reg)\/Th17 cell balance: a new paradigm for autoimmunity. Pediatr Res. 2009;65(5 Pt 2):26R\u201331R. Epub 2009\/02\/17. https:\/\/doi.org\/10.1203\/PDR.0b013e31819e76c7.","journal-title":"Pediatr Res"},{"issue":"2","key":"2464_CR85","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S1386-6346(00)00137-6","volume":"20","author":"M Kato","year":"2001","unstructured":"Kato M, Ikeda N, Matsushita E, Kaneko S, Kobayashi K. Involvement of IL-10, an anti-inflammatory cytokine in murine liver injury induced by concanavalin A. Hepatol Res. 2001;20(2):232\u201343. Epub 2001\/05\/12. https:\/\/doi.org\/10.1016\/S1386-6346(00)00137-6.","journal-title":"Hepatol Res"},{"issue":"1","key":"2464_CR86","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jhep.2012.02.029","volume":"57","author":"M Peiseler","year":"2012","unstructured":"Peiseler M, Sebode M, Franke B, Wortmann F, Schwinge D, Quaas A, et al. FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency. J Hepatol. 2012;57(1):125\u201332. Epub 2012\/03\/20. https:\/\/doi.org\/10.1016\/j.jhep.2012.02.029.","journal-title":"J Hepatol"},{"key":"2464_CR87","first-page":"461294","volume":"2015","author":"L Wang","year":"2015","unstructured":"Wang L, Du H, Liu Y, Ma X, Zhang W. Chinese medicine bu xu hua yu recipe for the regulation of treg\/th17 ratio imbalance in autoimmune hepatitis. Evid Based Complement Alternat Med. 2015;2015:461294 Epub 2015\/05\/16.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"4","key":"2464_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018909","volume":"6","author":"L Zhao","year":"2011","unstructured":"Zhao L, Tang Y, You Z, Wang Q, Liang S, Han X, et al. Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression. PLoS One. 2011;6(4):e18909. Epub 2011\/04\/29. https:\/\/doi.org\/10.1371\/journal.pone.0018909.","journal-title":"PLoS One"},{"issue":"5","key":"2464_CR89","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41409-017-0065-5","volume":"53","author":"E Calore","year":"2018","unstructured":"Calore E, Marzollo A, Cananzi M, Pizzi M, Rugge M, Rossin S, et al. Haploidentical stem cell transplantation cures autoimmune hepatitis and cerebrovascular disease in a patient with sickle cell disease. Bone Marrow Transplant. 2018;53(5):644\u20136. Epub 2018\/01\/18. https:\/\/doi.org\/10.1038\/s41409-017-0065-5.","journal-title":"Bone Marrow Transplant"},{"issue":"9026","key":"2464_CR90","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/S0140-6736(05)64700-9","volume":"348","author":"S Vento","year":"1996","unstructured":"Vento S, Cainelli F, Renzini C, Ghironzi G, Concia E. Resolution of autoimmune hepatitis after bone-marrow transplantation. Lancet. 1996;348(9026):544\u20135. Epub 1996\/08\/24. https:\/\/doi.org\/10.1016\/S0140-6736(05)64700-9.","journal-title":"Lancet."},{"issue":"1","key":"2464_CR91","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2017.014","volume":"9","author":"A Marzollo","year":"2017","unstructured":"Marzollo A, Calore E, Tumino M, Pillon M, Gazzola MV, Destro R, et al. Treosulfan-based conditioning regimen in sibling and alternative donor hematopoietic stem cell transplantation for children with sickle cell disease. Mediterr J Hematol Infect Dis. 2017;9(1):e2017014. Epub 2017\/03\/16. https:\/\/doi.org\/10.4084\/mjhid.2017.014.","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"2","key":"2464_CR92","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12016-020-08778-6","volume":"58","author":"SP Liu","year":"2020","unstructured":"Liu SP, Bian ZH, Zhao ZB, Wang J, Zhang W, Leung PSC, et al. Animal models of autoimmune liver diseases: a comprehensive review. Clin Rev Allergy Immunol. 2020;58(2):252\u201371. Epub 2020\/02\/23. https:\/\/doi.org\/10.1007\/s12016-020-08778-6.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"7","key":"2464_CR93","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1002\/stem.1129","volume":"30","author":"H Xin","year":"2012","unstructured":"Xin H, Li Y, Buller B, Katakowski M, Zhang Y, Wang X, et al. Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells. 2012;30(7):1556\u201364. Epub 2012\/05\/19. https:\/\/doi.org\/10.1002\/stem.1129.","journal-title":"Stem Cells"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02464-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-021-02464-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02464-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T11:09:32Z","timestamp":1625656172000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-021-02464-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,7]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2464"],"URL":"https:\/\/doi.org\/10.1186\/s13287-021-02464-w","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,7]]},"assertion":[{"value":"9 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"386"}}